Clinical Evaluation of a New Oral Anticoagulant "Sintrom"
- 1 May 1957
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 15 (5) , 713-720
- https://doi.org/10.1161/01.cir.15.5.713
Abstract
The clinical results in 100 patients treated for thromboembolic disorders were compared with 100 similar patients treated with Dicumarol. The rate of induction, ability to maintain a constant therapeutic level, and duration of action were especially considered. Induction and maintenance dosage were determined by clinical trial.Keywords
This publication has 7 references indexed in Scilit:
- An Evaluation of a New Anticoagulant, Acenocoumarin (Sintrom)Circulation, 1956
- PRESENT STATUS OF ANTICOAGULANT THERAPY IN THE TREATMENT OF MYOCARDIAL INFARCTION; THE USE AND MISUSE OF ANTICOAGULANTS; AN EVALUATION OF NEW ANTICOAGULANTS, THEIR INDICATIONS AND DOSAGEAnnals of Internal Medicine, 1955
- Dipaxin—2-Diphenylacetyl-1,3-Indandione; Clinical Evaluation of a New AnticoagulantCirculation, 1955
- Clinical Experience with a New Anticoagulant, Dipaxin (2-diphenylacetyl-l,3-indandione)Circulation, 1954
- Clinical evaluation of ethyl biscoumacetate (tromexan)The American Journal of Medicine, 1953
- THE PHYSIOLOGICAL DISPOSITION OF ETHYL BISCOUMACETATE (TROMEXAN) IN MAN AND A METHOD FOR ITS ESTIMATION IN BIOLOGICAL MATERIAL1952
- THE USE OF THE ANTICOAGULANTS IN THE TREATMENT OF DISEASES OF THE HEART AND BLOOD VESSELSAnnals of Internal Medicine, 1948